Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.650
+0.150 (3.33%)
Sep 16, 2025, 2:35 PM EDT - Market open
Precision BioSciences Stock Forecast
DTIL's stock price has decreased by -55.05% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover Precision BioSciences stock have a consensus rating of "Strong Buy" and an average price target of $47, which forecasts a 910.75% increase in the stock price over the next year. The lowest target is $34 and the highest is $60.
Price Target: $47 (+910.75%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 21, 2025.
Analyst Ratings
The average analyst rating for Precision BioSciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,190.32% | May 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,190.32% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,190.32% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,190.32% | Feb 19, 2025 |
| BMO Capital | BMO Capital | Hold → Buy Upgrades $34 | Hold → Buy | Upgrades | $34 | +631.18% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
11.02M
from 68.70M
Decreased by -83.96%
Revenue Next Year
25.91M
from 11.02M
Increased by 135.19%
EPS This Year
-5.29
from 1.04
EPS Next Year
-2.00
from -5.29
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.2M | 69.7M | |||
| Avg | 11.0M | 25.9M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -66.2% | 532.9% | |||
| Avg | -84.0% | 135.2% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -2.91 | 0.06 | ||
| Avg | -5.29 | -2.00 | ||
| Low | -7.74 | -4.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.